GlassScriptPhysician profile
Lori L Gordon
NPI 1053386045
$4,972.67
in general payments reported to CMS, 2019-2025
31 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,648 · 2020: $853 · 2021: $331 · 2022: $1,603 · 2023: $238 · 2024: $189 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $537.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,924.76 | 2019-2023 | Da Vinci Surgical System |
| Conmed Corporation | $1,600.00 | 2019-2020 | |
| Medtronic, INC. | $193.45 | 2022-2024 | Signia, Ligasure |
| Ethicon US, LLC | $188.39 | 2019-2023 | Enseal |
| Micro-Tech Endoscopy USA, INC. | $182.06 | 2019 | |
| Sirtex Medical INC | $111.88 | 2019 | |
| Stryker Corporation | $58.14 | 2021 | |
| Acell, INC. | $54.37 | 2019 | |
| Merck Sharp & Dohme LLC | $50.00 | 2019 | |
| Integra Lifesciences Corporation | $48.47 | 2022-2024 | Integra, Surgimend, Omnigraft |
| Baxter Healthcare | $48.04 | 2019-2021 | |
| Tela Bio, INC. | $45.81 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Innovation Technologies INC | $45.74 | 2023 | Irrisept |
| Janssen Pharmaceuticals, INC | $45.68 | 2019-2020 | |
| Axonics, INC. | $35.46 | 2021-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $35.01 | 2025 | Phasix Mesh |
| Covidien LP | $32.56 | 2019 | |
| Thd America, INC. | $28.30 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.29 | 2020 | |
| Reprise Biomedical, INC. | $26.02 | 2025 | Miro3d |
| Ambu INC. | $24.27 | 2022 | |
| Polynovo North America LLC | $19.85 | 2024 | Novosorb Btm |
| Shire North American Group INC | $19.72 | 2019 | |
| Cook Medical LLC | $18.98 | 2019 | |
| Prescient Surgical | $18.68 | 2019 | |
| Mimedx Group, INC. | $18.33 | 2025 | |
| Acera Surgical, INC. | $16.54 | 2025 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $15.44 | 2021 | |
| Hologic Sales and Service, LLC | $14.15 | 2024 | Coolseal Generator |
| Allergan, INC. | $13.59 | 2021 | |
| Braintree Laboratories, INC. | $11.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.